摘要
目的对血清CA125 检测联合PET/CT 显像在诊断早期卵巢癌中的应用于临床价值进行分析和探讨.方法： 取卵巢病变患者110 例为本次研究对象,对其实施血清CA125 检测联合全身18F-FDG PET/CT 显像.结果：在早期诊断卵巢癌过程中,18F-FDG PET/CT 显像灵敏度为95.1%,特异性为79.09%,阴性与阳性预测值分别为88.5%和93.1%,准确性为80.9%;在卵巢癌早期诊断效能方面,18F-FDG PETCT 显像在上述指标方面均高于血清CA125 检测,但18F-FDG PET/CT 显像与CA125检测联合可有效提高前者诊断准确性（88.3%）以及特异性（91.0%）.结论：联合18F-FDG PET/CT 显像与血清CA125 检测有利于早期诊断卵巢癌准确性与特异性的提高.
Objective To analyze and discuss the application and clinical value of serum CA125 detection combined with PET/CT imaging in the diagnosis of early ovariancancer. Methods： A total of 110 patients with ovarian lesions were taken as the subjects, who received serum CA125 detection combined with systemic 18F-FDG PET/CT imaging.Results： As for the early diagnostic efficiency of ovarian cancer, the above indicators of 18F-FDG PET/CT imaging were all higher than those of serum CA125 detection, but thecombination of 18F-FDG PET/CT imaging and CA125 detection can effectively improve the diagnostic accuracy of the former by 88.3% and the specificity by 91.0%. Conclusion： Thecombination of 18F-FDG PET/CT imaging and serum CA125 detection can help to improve the accuracy and specificity of early ovarian cancer diagnosis.
出处
《中医学报》
CAS
2014年第B07期127-127,共1页
Acta Chinese Medicine
